Mutations in SF3B1 have been implicated in myelodysplastic syndromes (MDS), chronic lymphocytic leukemia (CLL), chronic myeloid leukemia (CML) and a number of late-stage cancers. The gene discussed is SF3B1; the disease is myelodysplastic syndrome.